Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Gynecology | Internal Medicine | Nursing | Pharmacy | Journal

Back to Journal Articles

Ethinyl Estradiol Dose, Progestin Type Affect the Pill’s Stroke Risk

Last Updated: June 13, 2012.

 

However, risk of thrombotic stroke and myocardial infarction is generally low for oral contraceptives

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The risk of thrombotic stroke and myocardial infarction is increased for women who take oral contraceptives that include ethinyl estradiol, with the relative risk varying according to the dose of ethinyl estradiol and the progestin type, according to a study published in the June 14 issue of the New England Journal of Medicine.

WEDNESDAY, June 13 (HealthDay News) -- The risk of thrombotic stroke and myocardial infarction is increased for women who take oral contraceptives that include ethinyl estradiol, with the relative risk varying according to the dose of ethinyl estradiol and the progestin type, according to a study published in the June 14 issue of the New England Journal of Medicine.

Øjvind Lidegaard, Dr.Med.Sci., from the University of Copenhagen in Denmark, and colleagues utilized data from national registries to assess the risk of thrombotic stroke and myocardial infarction in 1,626,158 nonpregnant women (aged 15 to 49 years) with no history of cardiovascular disease or cancer.

Over the 15-year cohort study, the researchers found that there were 3,311 thrombotic strokes (21.4 per 100,000 person-years) and 1,725 myocardial infarctions (10.1 per 100,000 person-years). Compared with nonuse, current use of oral contraceptives that included 30 to 40 µg ethinyl estradiol correlated with an increased relative risk for thrombotic stroke and myocardial infarction which varied according to progestin type (1.5 to 2.2 and 1.3 to 2.3, respectively. Compared with nonuse, the relative risk with use of oral contraceptives that included 20 µg ethinyl estradiol was 0.9 to 1.7 and 0.0 to 1.6, respectively, for thrombotic stroke and myocardial infarction. The corresponding relative risks were 3.2 and 0.0 for transdermal patches and 2.5 and 2.1 for the vaginal ring.

"The absolute risks of thrombotic stroke and myocardial infarction associated with the use of hormonal contraception were low," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry; one author provided expert testimony in a legal case pertaining to the study.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Whole-Genome Sequencing Can Identify MRSA Outbreaks Next: Fatal Airway Necrosis Noted After Stereotactic Body Radiation

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.